Information Journal Paper
APA:
Copy. (2019). SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. CARDIOVASCULAR DIABETOLOGY, 18(1), 0-0. SID. https://sid.ir/paper/1027872/en
Vancouver:
Copy. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. CARDIOVASCULAR DIABETOLOGY[Internet]. 2019;18(1):0-0. Available from: https://sid.ir/paper/1027872/en
IEEE:
Copy, “SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart,” CARDIOVASCULAR DIABETOLOGY, vol. 18, no. 1, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/1027872/en